Cargando…

Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study

AIMS: To evaluate the efficacy and safety of elobixibat in patients with diabetes and concomitant chronic constipation. METHODS: This was a single-center, single-arm study. Thirty-three patients with diabetes and chronic constipation, as defined by the Rome IV criteria, were treated with elobixibat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hishida, Yoshiaki, Nagai, Yoshio, Tsukiyama, Hidekazu, Nakamura, Yuta, Nakagawa, Tomoko, Ishizaki, Sonoko, Tanaka, Yasushi, Sone, Masakatsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402500/ https://www.ncbi.nlm.nih.gov/pubmed/35867276 http://dx.doi.org/10.1007/s12325-022-02243-w

Ejemplares similares

A retrospective cohort study for the treatment of Asian diabetic ketoacidosis: optimizing initial doses of insulin
por: Hishida, Yoshiaki, et al.
Publicado: (2021)

Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation
por: Nakajima, Atsushi, et al.
Publicado: (2022)

Treatment of Chronic Constipation using Elobixibat in a Real-World Setting: A Retrospective Cohort Study using an Electronic Medical Records Database in Japan
por: Masaki, Hisanori, et al.
Publicado: (2023)

Elobixibat improves rectal sensation in patients with chronic constipation aged ≥60 years: a randomised placebo-controlled study
por: Manabe, Noriaki, et al.
Publicado: (2023)

Efficacy and Safety of Elobixibat in Elderly Patients with Chronic Constipation: A Single-center, Observational Study
por: Abe, Tatsuya, et al.
Publicado: (2020)

Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial
por: Kumagai, Yuji, et al.
Publicado: (2018)

Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake
por: Ozaki, Anna, et al.
Publicado: (2021)

Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study
por: Kamei, Daigo, et al.
Publicado: (2020)

The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study
por: Tomie, Akira, et al.
Publicado: (2020)

Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation
por: Yamamoto, Atsushi, et al.
Publicado: (2022)

Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease
por: Matsuyama, Momoko, et al.
Publicado: (2022)

Correction to: Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake
Publicado: (2023)

Uncontrolled, Open-Label Pre-Dinner Administration of Elobixibat in Japanese Adults with Chronic Constipation: A Retrospective Chart Review
por: Odaka, Takeo, et al.
Publicado: (2020)

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
por: Tanaka, Kosuke, et al.
Publicado: (2022)

Effect of Eating Glutinous Brown Rice Twice a Day for 6 Weeks on Serum 1,5-Anhydroglucitol in Japanese Subjects without Diabetes
por: Nakayama, Taiga, et al.
Publicado: (2020)

Efficacy, long‐term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan
por: Nakajima, Atsushi, et al.
Publicado: (2019)

Safety and Efficacy of Elobixibat, an Ileal Bile Acid Transporter Inhibitor, in Elderly Patients With Chronic Idiopathic Constipation According to Administration Time: Interim Analysis of Post-marketing Surveillance
por: Nakajima, Atsushi, et al.
Publicado: (2022)

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group study (CONST-PD)
por: Hatano, Taku, et al.
Publicado: (2022)

Efficacy of elobixibat as bowel preparation agent for colonoscopy: Prospective, randomized, multi‐center study
por: Yamaguchi, Daisuke, et al.
Publicado: (2021)

Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease
por: Iwaki, Michihiro, et al.
Publicado: (2023)

Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial
por: Suichi, Tomoki, et al.
Publicado: (2020)

Mediterranean Diet Adherence in People With Parkinson's Disease Reduces Constipation Symptoms and Changes Fecal Microbiota After a 5-Week Single-Arm Pilot Study
por: Rusch, Carley, et al.
Publicado: (2021)

Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial
por: Nakajima, Atsushi, et al.
Publicado: (2017)

Magnesium Oxide in Constipation
por: Mori, Hideki, et al.
Publicado: (2021)

Impact of ao-dake-humi, Japanese traditional bamboo foot stimulator, on lower urinary tract symptoms, constipation and hypersensitivity to cold: a single-arm prospective pilot study
por: Minagawa, Tomonori, et al.
Publicado: (2016)

Proposed cut‐off values of the waist circumference for metabolic syndrome based on visceral fat volume in a Japanese population
por: Tsukiyama, Hidekazu, et al.
Publicado: (2016)

Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series
por: Ishii, Satoshi, et al.
Publicado: (2019)

Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study
por: Ozaki, Anna, et al.
Publicado: (2020)

Differing Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Ipragliflozin on the Decrease of Fat Mass vs. Lean Mass in Patients With or Without Metformin Therapy
por: Nagai, Yoshio, et al.
Publicado: (2019)

Reduced-port endo-laparoscopic surgery using umbilical zigzag incision for concomitant operations: A case series
por: Umeda, Shinichi, et al.
Publicado: (2018)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
por: Misawa, Sonoko, et al.
Publicado: (2023)

Timed sequential chemotherapy with concomitant Granulocyte Colony-Stimulating Factor for high-risk acute myelogenous leukemia: a single arm clinical trial
por: He, Xing-Yue, et al.
Publicado: (2002)

Evaluation of Remdesivir for Mildly to Moderately Ill Patients with COVID-19: A Single-Arm, Single-Center, Retrospective Study
por: Miyazaki, Motoyasu, et al.
Publicado: (2022)

Right Upper Arm Lymphedema Secondary to Exercise-related Rhabdomyolysis
por: Nakagawa, Hiroaki, et al.
Publicado: (2019)

Clinical Practice Changes After Post-Market Safety Reports on Desmopressin Orally Disintegrating Tablet in Japan: A Single-Center Retrospective Study
por: Yasuda, Takuma, et al.
Publicado: (2021)

Proprioceptive Interaction between the Two Arms in a Single-Arm Pointing Task
por: Kigawa, Kazuyoshi, et al.
Publicado: (2015)

Signal Quality Analysis of Single-Arm Electrocardiography
por: Wang, Jia-Jung, et al.
Publicado: (2023)

Multi-Component Intervention to Promote Physical Activity in Japanese Office Workers: A Single-Arm Feasibility Study
por: Kim, Jihoon, et al.
Publicado: (2022)

AB149. A novel single-armed technique for microsurgical vasoepididymostomy: the reverse single-armed 2-suture longitudinal intussusception
por: Li, Peng, et al.
Publicado: (2014)

Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease
por: Kessoku, Takaomi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6tnj43gdmd8ajif5s510cqab4s